The University of Miami Board of Trustees has unanimously selected Dipen J. Parekh, M.D., as the next chief executive officer of UHealth – University of Miami Health System, as well as executive vice president for health affairs at the University of Miami.
Dr. Parekh, a globally renowned urologic oncologist, health care innovator and leader in academic medicine, has served as the chief operating officer of UHealth since 2020, and, alongside University of Miami President Joseph J. Echevarria, jointly engineered UHealth’s dramatic turnaround during the past five years.
“Dipen has played a pivotal role each step of the way as the University of Miami Health System has grown into one of the top academic medical centers in the country,” noted President Echevarria. “He understands the mission — from the operating room to the classroom to the boardroom — and he embodies the excellence we strive to deliver for our patients, students and community.”
“I am profoundly grateful for the trust placed in me and energized by the opportunity to advance our shared mission of delivering world-class care, pioneering research and transformative education,”
Having joined the institution in 2012 as chair of the Department of Urology, Dr. Parekh’s first system-wide administrative role was as chief clinical officer from 2017 to 2020. He is also an endowed professor of urology and the founding director of the Desai Sethi Urology Institute. Over the course of his career, he has performed more than 6,000 robotic urologic cancer surgeries, making him one of the most experienced practitioners worldwide. As he has throughout his tenure at the University of Miami, Dr. Parekh will continue to treat patients.
“I am profoundly grateful for the trust placed in me and energized by the opportunity to advance our shared mission of delivering world-class care, pioneering research and transformative education,” Dr. Parekh said. “I look forward to working with our exceptional faculty, staff and our key partner, the Jackson Health System, to lead us into this next chapter, one grounded in collaboration, compassion and a bold vision for the future of academic medicine.”
